Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

Published Date: 03 Jun 2025

Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

2.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

3.

Resection for Early Liver Cancer Tied to Improved Survival.

4.

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

5.

Prior authorizations draining time, energy from many cancer patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot